Aspects of healthcare utilisation in self-reported obstructive lung disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20298370)

Published in Clin Respir J on January 01, 2009

Authors

Rune Nielsen1, Ane Johannessen, Per Sigvald Bakke, Jan Erik Askildsen, Ernst Reidar Omenaas, Amund Gulsvik

Author Affiliations

1: Institute of Medicine, University of Bergen, Haukeland University Hospital, Bergen, Norway. rune.nielsen@med.uib.no

Articles by these authors

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2003) 10.97

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12

Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet (2009) 6.93

Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44

The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med (2007) 2.91

Body mass index, weight gain, and other determinants of lung function decline in adult asthma. J Allergy Clin Immunol (2009) 2.16

Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med (2006) 2.15

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98

Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol (2007) 1.83

Pet-keeping in childhood and adult asthma and hay fever: European community respiratory health survey. J Allergy Clin Immunol (2003) 1.83

Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax (2010) 1.82

Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med (2009) 1.75

Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. J Clin Epidemiol (2002) 1.75

Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72

The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol (2012) 1.70

Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med (2012) 1.49

Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One (2012) 1.47

Occupational airborne exposure and the incidence of respiratory symptoms and asthma. Am J Respir Crit Care Med (2002) 1.46

Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. Am J Epidemiol (2003) 1.43

Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med (2013) 1.42

Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. Am J Epidemiol (2002) 1.40

Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med (2010) 1.36

Explained variance for blood gases in a population with COPD. Clin Respir J (2011) 1.27

Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol (2006) 1.19

Genome-wide association study of smoking behaviours in patients with COPD. Thorax (2011) 1.18

The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol (2011) 1.17

A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease. Value Health (2004) 1.17

Early age at menarche, lung function, and adult asthma. Am J Respir Crit Care Med (2010) 1.15

Exposure to environmental tobacco smoke in a general population. Respir Med (2006) 1.11

Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One (2011) 1.11

The adult incidence of asthma and respiratory symptoms by passive smoking in uterus or in childhood. Am J Respir Crit Care Med (2005) 1.10

Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med (2007) 1.10

Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med (2013) 1.08

Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 1.04

α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest (2010) 1.02

Hospital doctors' attitudes toward giving their patients smoking cessation help. Clin Respir J (2007) 1.01

Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Hum Mol Genet (2009) 1.01

Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J (2010) 1.00

Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med (2010) 0.99

Quantitative CT: Associations between Emphysema, Airway Wall Thickness and Body Composition in COPD. Pulm Med (2011) 0.99

Atopic and non-atopic asthma in a farming and a general population. Am J Ind Med (2004) 0.95

Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med (2006) 0.95

Menstrual irregularity and asthma and lung function. J Allergy Clin Immunol (2007) 0.93

Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet (2013) 0.92

Diagnostic validity of fatal cerebral strokes and coronary deaths in mortality statistics: an autopsy study. Eur J Epidemiol (2010) 0.92

Feasible and simple exclusion criteria for pulmonary reference populations. Thorax (2007) 0.92

Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax (2011) 0.91

Changes in respiratory symptoms and health-related quality of life. Chest (2007) 0.91

Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med (2013) 0.91

Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol (2007) 0.91

Young maternal age at delivery is associated with asthma in adult offspring. Respir Med (2007) 0.90

Does smoking affect the outcome of patient education and self-management in asthmatics? Patient Educ Couns (2003) 0.90

Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 0.90

Asthma severity according to Global Initiative for Asthma and its determinants: an international study. Int Arch Allergy Immunol (2009) 0.90

Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist. Pulm Pharmacol Ther (2005) 0.90

The effect of educational level on the incidence of asthma and respiratory symptoms. Respir Med (2004) 0.90

Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly. Respir Med (2004) 0.89

Oral contraception, body mass index, and asthma: a cross-sectional Nordic-Baltic population survey. J Allergy Clin Immunol (2009) 0.89

Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. Am J Respir Crit Care Med (2010) 0.89

Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. Genomics (2013) 0.89

Respiratory symptoms and long-term cardiovascular mortality. Respir Med (2007) 0.88

Occupational exposure and incidence of respiratory disorders in a general population. Scand J Work Environ Health (2009) 0.87

Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clin Respir J (2010) 0.86

Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. Respir Med (2002) 0.85

Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community. Respir Med (2006) 0.84

Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations. Int J Cancer (2012) 0.84

HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer. Clin Respir J (2010) 0.84

[Instructing patients in the correct use of inhalation devices]. Tidsskr Nor Laegeforen (2006) 0.83

Increased awareness of COPD in the Norwegian population. Clin Respir J (2007) 0.83

[Prevalence of home ventilation therapy in Norway]. Tidsskr Nor Laegeforen (2009) 0.83

An economic model to evaluate cost-effectiveness of computer assisted knee replacement surgery in Norway. BMC Musculoskelet Disord (2013) 0.83

Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe. Eur J Epidemiol (2014) 0.82

Genetic heterogeneity of asthma phenotypes identified by a clustering approach. Eur Respir J (2013) 0.82

Excessive costs of COPD in ever-smokers. A longitudinal community study. Respir Med (2010) 0.82

The association between lung function and fatal stroke in a community followed for 4 decades. J Epidemiol Community Health (2012) 0.81

Predictors of health-related quality of life changes after lifestyle intervention in persons at risk of type 2 diabetes mellitus. Qual Life Res (2014) 0.81

The impact of different prioritisation policies on waiting times: case studies of Norway and Scotland. Soc Sci Med (2013) 0.81

Early life environment and snoring in adulthood. Respir Res (2008) 0.80

On the simultaneous association analysis of large genomic regions: a massive multi-locus association test. Bioinformatics (2013) 0.80

Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. Respir Res (2014) 0.80

Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol (2007) 0.80

Prevalence and predictors of symptoms in the terminal stage of lung cancer: A community study. Chest (2007) 0.79

On the follow-up of genome-wide association studies: an overall test for the most promising SNPs. Genet Epidemiol (2011) 0.79

Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2014) 0.78

Folic acid supplementation and interpregnancy interval. Paediatr Perinat Epidemiol (2014) 0.78

How frequently are physiological variables recorded in the emergency room in patients with obstructive pulmonary diseases and pneumonia? Prim Care Respir J (2009) 0.77